8-K filing — Advasa Holdings, Inc. (ADBT)
Filed: 2026-10-16 AccNo: 0001493152-26-047434 Size: 245 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
Snowflake shares surged 24% after Q2 revenue and earnings beat estimates; other premarket gainers and losers made notable moves.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Advasa Holdings Board Adopts Dividend Policy Targeting Annual Cash Dividend Payout Ratio Of 50% For Its Common Stock, Beginning With Fiscal Year Ending March 31, 2027
Advasa Holdings, Inc. (NASDAQ:ADBT) ("ADVASA" or the "Company"), a fintech payment holding company delivering Earned Wage Access ("EWA") and financial infrastructure solutions, today announced
Shares of enterprise software companies are trading higher amid an investor rotation from highly leveraged AI-exposed names into the legacy tech services sector. Fears of persistently high inflation and interest rates may increase the appeal of the industry's proven business models.
Advasa Announces FY2031 Targets Of $632.91M Revenue, $189.87M Operating Income, Rising From FY2027 Targets Of $18.99M, $1.9M
8-K filing — BioRestorative Therapies, Inc. (BRTX)
Filed: 2026-10-09 AccNo: 0001213900-26-108467 Size: 198 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Maxim Group Downgrades BioRestorative Therapies to Hold
Maxim Group analyst Michael Okunewitch downgrades BioRestorative Therapies (NASDAQ:BRTX) from Buy to Hold.